All Cancers
|
Incidence |
Modifiable risk factors |
Reduce smoking, obesity, physical inactivity & alcohol consumption |
Lung
|
Incidence |
Modifiable risk factors |
Increase smoking cessation; prevent initiation |
|
Mortality |
Screening (Early detection) |
Increase low-dose CT uptake and reduce disparities in use |
|
|
Treatment |
Reduce disparities in access to more effective treatments (targeted and immune-based therapies for NSCLC) |
Colorectal
|
Incidence |
Screening (Prevention) |
Increase uptake of colonoscopy, flexible sigmoidoscopy, and FIT/FIT-DNA for hard-to-reach populations |
|
|
Preventive treatment |
Increase adherence to diagnostic follow-up and polyp removal |
|
Mortality |
Screening (Early detection) |
Increase uptake of colonoscopy, flexible sigmoidoscopy; gFOBT and FIT with diagnostic follow-up |
Pancreas
|
Mortality |
Treatment |
Develop and evaluate new mutant KRAS inhibitors |
Breast
|
Incidence |
Preventive treatment |
Evaluate efficacy of low-dose hormone therapies & improve risk-stratification |
|
Mortality |
Modifiable risk factors post-diagnosis |
Evaluate strategies for increasing physical activity and decreasing obesity in survivors |
|
|
Screening (Early detection) |
Increase mammography uptake amongst under-served populations |
|
|
Treatment |
Increase uptake/adherence to hormone therapy and chemotherapy especially in under-served populations |
Prostate
|
Mortality |
Screening (Early detection) |
Evaluate risk-stratified PSA screening & improved diagnostic testing |
|
|
Treatment |
Evaluate strategies to further reduce over treatment and reduce disparities |
Liver
|
Incidence |
Modifiable risk factors |
Increase uptake of HBV and HCV treatments, decrease smoking prevalence |
|
Mortality |
Screening (Early detection) |
Increase cirrhosis diagnosis and screening uptake |